INS and type 2 diabetes mellitus: Genetic studies of T2D intermediate phenotypes (such as plasma glucose, insulin, and HbA1c) have identified regions involved in glycaemic regulation in non-diabetic individuals [35–37], many but not all of which also increase the risk of T2D [33, 35].